The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases
- 15 July 2021
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 16 (11) , 1287-1305
Abstract
Phospholipase A2 (PLA2) enzymes are implicated in several pathological conditions such as arthritis, cardiovascular diseases, and diabetes. It is highly important to regulate their activity and develop PLA2 inhibitors as new agents to treat inflammatory diseases.Keywords
Funding Information
- not funded
This publication has 125 references indexed in Scilit:
- Fluoroketone Inhibition of Ca2+-Independent Phospholipase A2 through Binding Pocket Association Defined by Hydrogen/Deuterium Exchange and Molecular DynamicsJournal of the American Chemical Society, 2013
- Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic InterventionChemical Reviews, 2011
- Phospholipase A 2 superfamily members play divergent roles after spinal cord injuryThe FASEB Journal, 2011
- Inhibition of secreted phospholipases A2 by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculationsBioorganic & Medicinal Chemistry, 2011
- Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studiesThe Lancet, 2010
- Potent and Selective Fluoroketone Inhibitors of Group VIA Calcium-Independent Phospholipase A2Journal of Medicinal Chemistry, 2010
- Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitisBrain, 2009
- Synthesis of Polyfluoro Ketones for Selective Inhibition of Human Phospholipase A2EnzymesJournal of Medicinal Chemistry, 2008
- Crystal Structure of Human Plasma Platelet-activating Factor AcetylhydrolaseJournal of Biological Chemistry, 2008
- Intracellular phospholipase A2 group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injuryBrain, 2008